Evidence map›Paper›PMID 36824443›Full record

ArticleJournal of ophthalmology2023

Mini-

Qianyin Chen, Huimin Lin, Shengnan Li, Xuan Deng, Jinglin Zhang

Open access · goldAbstract read
In one paragraph

Article in Journal of ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Qianyin ChenGuangzhou Aier Eye Hospital, Jinan University, Guangzhou 510040, China.
Huimin LinGuangzhou Aier Eye Hospital, Jinan University, Guangzhou 510040, China.
Shengnan LiSichuan Eye Hospital, Aier Eye Hospital Group, Chengdu 610047, China.
Xuan DengThe First Affiliated Hospital of Chongqing Medical University, Chongqing 420030, China.
Jinglin ZhangGuangzhou Aier Eye Hospital, Jinan University, Guangzhou 510040, China.ORCID https://orcid.org/0000-0002-9801-9847
Jinan University · CNCentral South University · CNThe Affiliated Yongchuan Hospital of Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Age-related macular degeneration (AMD) is the leading cause of serious vision loss in the elderly. Regulating microRNA (miRNA) gene expression offers exciting new avenues for treating AMD. This study aimed to investigate whether miRNAs and their target genes play an antiapoptotic role during oxidative stress-induced apoptosis of retinal pigment epithelial (RPE) cells via mini- Methods: ARPE-19 cells were treated with 3.5 mM NaIO3 for 48 h to establish a retinal degeneration model. Cells were treated with mini- Results: NaIO3 can induce oxidative damage and promote apoptosis. Conversely, mini- Conclusions: miR-155-5p promotes the antioxidative damage and antiapoptotic effects of mini-

Identifiers

PMID36824443
PMCPMC9943629
OpenAlexW4320718788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.